...
首页> 外文期刊>Cancer causes and control: CCC >Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: The Malm? Diet and Cancer Cohort
【24h】

Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: The Malm? Diet and Cancer Cohort

机译:初生年龄和口服避孕药与雄激素受体阴性乳腺癌的风险有关:饮食与癌症队列

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Risk factors for breast cancer vary according to breast cancer subtype. This study analyzes the impact of potential risk factors in breast cancer by androgen receptor (AR) status. Methods: A total of 17,035 women were followed in the population-based prospective Malm? Diet and Cancer Study. Baseline data included lifestyle factors including anthropometry, reproductive history, and exogenous hormone use. During follow-up (mean: 12.8 years), 747 invasive breast cancers were diagnosed. Expression of AR was determined by immunohistochemistry in tumor tissue microarrays. Results: AR status was assessable in 516 of 747 tumors (69%). Among these, 467 tumors (90.5%) were AR positive (AR+) and 49 tumors (9.5%) were AR negative (AR -). AR negativity was significantly associated with estrogen receptor (ER) and progesterone receptor negativity, higher grade and proliferation (Ki67). Cox regression analyses stratified by AR status showed significant associations between reproductive factors and AR- breast cancer. The older the woman at first childbirth the higher the risk of AR- breast cancer; adjusted HR≤20yrs = 0.35, HR20-≤25yrs = 0.62, HRnulliparous = 1.00, HR25-≤30yrs = 1.29, HR30yrs = 1.92, p trend = 0.001. No such association was seen for AR+ tumors. Similarly, ever oral contraceptive use increased the risk of AR- breast cancer [Adj. HR = 2.59, 95% CI (1.26-5.34)] compared to never use, but not for AR+ breast cancer. Conclusions: Advanced age at first child birth and use of oral contraceptives were associated with increased risk of AR- breast cancer. This study may contribute to enhanced understanding of the role of the AR in breast carcinogenesis and improve risk stratification tools for personalized breast cancer prevention.
机译:目的:乳腺癌的危险因素因乳腺癌亚型而异。这项研究分析了雄激素受体(AR)状态对乳腺癌潜在危险因素的影响。方法:在以人群为基础的前瞻性马尔姆?饮食与癌症研究。基线数据包括生活方式因素,包括人体测量,生殖史和外源激素使用。在随访期间(平均:12.8年),诊断出747例浸润性乳腺癌。通过免疫组织化学在肿瘤组织微阵列中确定AR的表达。结果:747例肿瘤中有516例(69%)可评估AR状态。其中,467例肿瘤(90.5%)为AR阳性(AR +),49例肿瘤(9.5%)为AR阴性(AR-)。 AR阴性与雌激素受体(ER)和孕激素受体阴性,更高的品位和增殖(Ki67)显着相关。按AR状态分层的Cox回归分析显示,生殖因素与AR-乳腺癌之间存在显着关联。刚分娩的妇女年龄越大,患AR乳腺癌的风险越高;调整后的HR≤20yrs= 0.35,HR>20-≤25yrs= 0.62,HR核糖体= 1.00,HR>25-≤30yrs= 1.29,HR> 30yrs = 1.92,p趋势= 0.001。对于AR +肿瘤,没有发现这种关联。同样,口服避孕药也会增加AR乳腺癌的风险[Adj。与从未使用相比,HR = 2.59,95%CI(1.26-5.34)],但对于AR +乳腺癌则没有。结论:初生婴儿高龄和使用口服避孕药与AR乳腺癌风险增加有关。这项研究可能有助于加深对AR在乳腺癌致癌作用中的作用的了解,并改善个性化乳腺癌预防的风险分层工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号